Up Next
Back to Show
Aging Matters
How Gene Therapy Could Change Vision Loss
At 88, Anette McRay faced fading vision from age-related macular degeneration and endured constant eye injections to slow her vision loss. But after she joined an experimental gene therapy trial at Vanderbilt Eye Institute, her sight, as well as her independence, is being preserved, offering hope for millions facing the same devastating disease.
Support Provided By
28:33
Nutrition & Aging examines the hidden epidemic of malnutrition and undernutrition.
26:46
Since 2011, it's estimated that 10,000 baby boomers turn 65 every day in the US.
57:37
Explores the impact these diseases are having on individuals, families and communities.
28:15
The fifth installment in Nashville Public Television’s NPT Reports: Aging Matters series.
26:22
The future is always uncertain, but what is important is that we take time to look ahead.
57:30
In NPT Reports Aging Matters: The New Old Age, NPT explores the changing face of aging.
58:59
End of Life explores the experience of dying and why so few of us get the death we want.